22 - 25 November 2022
Given the ongoing COVID-19 pandemic, participants must adhere to the host country’s entry requirements, recommended preventative measures, and are expected to have adequate medical and travel insurance coverage. Meeting organizers will not bear any cost in relation to a participant testing positive to COVID-19 and to any quarantine measures applied by the relevant authorities to travelers coming to or retuning from the meeting venue.
|
Provisional agenda, annotations and proposed organization of work |
|
|
Note by the Secretariat transmitting the "Report of the Secretariat on the world situation with regard to drug trafficking" (E/CN.7/2022/5 ) |
|
|
Report of the Secretariat on the current situation with respect to regional and subregional cooperation (2022) |
|
|
Note by the Secretariat on the implementation of the recommendations adopted by the Subcommission at its Fifty-fourth session |
|
|
Note by the Secretariat on the organization of the Fifty-sixth session of the Subcommission |
|
|
Report of the Fifty-fifth session of the Subcommission on Illicit Drug Traffic and Related Matters in the Near and Middle East |
| A - E - R | Questionnaire on the implementation of the recommendations adopted by the Subcommission at its Fifty-fourth session |
| A - E - R | Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem |
| A - E - R | Joint Ministerial Statement of the 2014 High-Level Review by the Commission on Narcotic Drugs of the Implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem |
| A/RES/S-30/1 | Outcome document adopted by the General Assembly at its special session on the world drug problem (19-21 April 2016, New York), entitled "Out joint commitment to effectively addressing and countering the world drug problem" |
| A - E - R | Ministerial Declaration on strengthening our actions at the national, regional and international levels to accelerate the implementation of our joint commitments to address and counter the world drug problem |
